Back to search
Polycystic Liver Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Polycystic Liver Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Polycystic Liver Disease trials you may qualify forNonalcoholic steatohepatitis (NASH), or fat-related liver inflammation and scarring is projected to be the leading cause of cirrhosis in the United States (U.S.…
The researchers want to learn how androgens, a type of sex hormone, might affect nonalcoholic fatty liver (NAFLD) in young women over time. NAFLD happens when f…
An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/li…
Multicentre, observational registry studying the natural course of polycystic liver disease.
General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less…
Complain of obstructive sleeping apnea and fatty liver is common in PCOS women so lifestyle changes are recommended
This is a multicenter, phase 2A, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of Saroglitazar Magnesium in wo…
Background and Objectives: Polycystic ovary syndrome (PCOS) and nonalcoholic fatty liver disease (NAFLD) commonly co-occur and are associated with insulin resi…